Global Exporter & Bulk Supplier: Regolieva 40mg Tablet
🌍 Market Overview
Are you searching for a highly dependable international supply chain partner for advanced targeted oncology therapeutics?
Ernest Oncology (a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) operates as a premier global exporter, bulk supplier, and distributor of Regolieva 40mg Tablets. Utilizing a fully compliant, professional pharmaceutical logistics framework, we manage efficient, high-capacity export operations to deliver premium Regorafenib 40mg directly to hospital networks, specialty clinics, pharmacy chains, and international medicine wholesale groups across the USA, UK, Australia, and South Africa.
🔬 Product Profile: Regolieva 40mg Tablet
Regolieva 40mg contains Regorafenib, a potent, oral, small-molecule multi-kinase inhibitor. It acts at the cellular level to target and inhibit a wide range of protein kinases involved in tumor cell proliferation, tumor angiogenesis (the formation of new blood vessels), and the maintenance of the tumor microenvironment.
Active Ingredient: Regorafenib (40mg)
Therapeutic Class: Antineoplastic / Multi-Kinase Inhibitor
Primary Indications:
Metastatic Colorectal Cancer (CRC): For patients previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, anti-VEGF biological therapies, and (if RAS wild-type) anti-EGFR therapies.
Gastrointestinal Stromal Tumors (GIST): For patients with locally advanced, unresectable, or metastatic disease who have previously progressed on or are intolerant to imatinib and sunitinib therapies.
Hepatocellular Carcinoma (HCC): Formulated for liver cancer patients who have been previously treated with sorafenib.
📦 Logistics & Sourcing Capabilities
Compliant Supply Lines: Sourced directly through strictly validated pharmaceutical channels operating in total alignment with international GMP compliance protocols.
Streamlined Global Export: Specialized logistics pathways custom-engineered to seamlessly manage strict customs entry protocols, documentation, and regulatory clearances inside the USA, UK, Australia, and South Africa.
Institutional Sourcing Power: Fully capable of supporting consistent, high-volume contract wholesale fulfillments for healthcare ministries, clinical groups, and international pharmaceutical networks.
B2B Documentation Suite: Delivery of full documentation portfolios including validated Certificates of Analysis (COA), export invoices, and batch traceability sheets.
PRESCRIPTION MEDICINE IS :YES
⚠️Disclaimer
Regolieva 40mg Tablet is a high-potency, targeted prescription antineoplastic medication. It must be administered strictly under the direct guidance, prescription, and supervision of a registered medical oncologist or specialized healthcare physician. The information listed here is compiled exclusively for B2B procurement, wholesale trade, and international pharmaceutical distribution networks; it does not serve as a substitute for professional clinical medical advice.
📞 Contact Ernest Oncology — Global Medicine Exporter
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 WhatsApp Direct Link:https://wa.me/919359902383
